New findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
Groundbreaking findings from the landmark CLEAR (Clinical trial Comparing Lenvatinib with Ecerolimus or Pembrolizumab in ...
I thought I had a UTI – then my GP’s voice grew serious
I finally booked an e-consult with my GP, a month after the initial red flag. The doctor’s voice grew serious as I spoke over ...
Cure Today2d
Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a ...
Odessa American2d
ASCO GU Symposium announces new findings on tumor reduction and survival outcomes in advanced renal cell carcinoma
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Cure Today3d
Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based ...
Targeted Oncology4d
Avelumab Maintenance With Axitinib Interruption Feasible in Kidney Cancer
Avelumab maintenance with axitinib interruption was feasible in metastatic renal cell carcinoma responders, according to ...
Renal & Urology News3d
Excess COPD Deaths Found in Renal Cell Carcinoma Population
In the United States, patients with renal cell carcinoma are more likely to die from COPD than the general population. Chronic obstructive pulmonary disease (COPD) is a major cause of death among ...
ascopubs.org5d
Non-clear cell renal cell carcinoma in the immune checkpoint era: A retrospective study on survival and treatment approaches.
Impact of initial local therapy (LT) in the combination treatment era for metastatic renal cell carcinoma (mRCC): Subgroup analysis from ProPaxi study. Mortality risk in clinical T1a renal cell ...
Targeted Oncology22h
TiNivo-2 Study Shows Comparable Patient-Reported Outcomes in RCC
Kathryn Beckermann, MD, PhD, discusses the patient-reported outcomes for tivozanib plus nivolumab from the phase 3 TiNivo-2 ...
Too Old to Operate4d
Risk Factors and Survival After Nephrectomy and Thrombectomy in RCC
The following is a summary of “Risk factors for renal insufficiency and survival implications after radical nephrectomy and ...
The American Journal of Managed Care5d
Real-World Data Support First-Line Avelumab Plus Axitinib in Advanced RCC
Real-world data confirmed the findings of JAVELIN Renal 101, supporting the combination of avelumab and axitinib in advanced renal cell carcinoma (RCC), said Axel Merseburger, MD, University Hospital ...
ascopubs.org5d
Safety and efficacy of immune checkpoint inhibitor rechallenge in metastatic fumarate hydratase-deficient renal cell carcinoma: A retrospective study.
Metastatic renal cell carcinoma (mRCC) primary refractory patients to first-line IO-TKI and IO-IO combinations (Meet-URO 33 analysis). This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary ...